Current filters:


Lumara Health to be acquired in two separate deals for up to $1.107 billion

Lumara Health to be acquired in two separate deals for up to $1.107 billion


Closely-held USA-based Lumara Health (previously K-V Pharmaceutical) today announced that it has entered…

AMAG PharmaceuticalsClindesseEvamistGynazoleLumara HealthMakenaMergers & AcquisitionsPerrigoPharmaceuticalUSAWomen's Health

Perrigo sells some preclinical assets to Imago

Perrigo sells some preclinical assets to Imago


US heath care firm Perrigo says it has transferred a portfolio of preclinical research assets, which…

Imago PharmaceuticalsMergers & AcquisitionsNeurologicalPerrigoPharmaceuticalUSA

Perrigo transfers ELND005 assets; buys OTC products


Drugmaker Perrigo has entered into a series of agreements with existing collaboration partner, Transition…

ELND005Mergers & AcquisitionsNeurologicalPerrigoPharmaceuticalResearchTransition Therapeutics

July a strong month for life sciences IPOs and M&A


The life sciences initial public offering (IPO) market continued to heat up in July as six life sciences…

BiotechnologyCubist PharmaceuticalsFinancialMergers & AcquisitionsPerrigoPharmaceuticalRoche

Elan board agrees $8.6 billion takeover bid


US health care company Perrigo (NYSE: PRGO) revealed this morning that Ireland-based drugmaker Elan Corp…

ElanGenericsMergers & AcquisitionsPerrigoPharmaceuticalTysabri

Perrigo acquires UK drugmaker Rosemont for £180 million


USA-based Perrigo (Nasdaq: PRGO) has signed a definitive merger agreement and has completed the acquisition…

GenericsMergers & AcquisitionsPerrigoPharmaceuticalRosemont Pharmaceuticals

Perrigo buys full control of Cobrek Pharma for about $45 million


US drugmaker Perrigo (Nasdaq: PRGO; TASE) announced on Friday that it has signed a definitive merger…

Cobrek PharmaceuticalsGenericsMergers & AcquisitionsPerrigoPharmaceutical

Back to top